NewsBenzingaNovo Nordisk Announces New Retrospective Real-world Evidence For Type 2 Diabetes Showing Semaglutide Injection 2 Mg Was Associated With A Statistically Significant 6% Lower Risk Of Major Adverse Cardiovascular Events, Than Those Who Switched To... Novo Nordisk Announces New Retrospective Real-world Evidence For Type 2 Diabetes Showing Semaglutide Injection 2 Mg Was Associated With A Statistically Significant 6% Lower Risk Of Major Adverse Cardiovascular Events, Than Those Who Switched To... Benzinga 2026.09.29 10:35 (GMT+0) Open on Benzinga Other news Galaxy Digital shares fall 8% Friday, weekly decline exceeds 20% Lean Groups Certify Claude-Assisted Riemann Proof Here are the top AI agents that can live in your text messages Coatue Management Bets on SK hynix Stock as Demand for HBM Chips Accelerates Target, Biotech Lead 5 Stocks Showing Strength In Brutal Market Morgan Stanley "Buys the Dip," Adding Nearly 800 Bitcoin to Lift Total Holdings to 12,448 BTC